Research

This Special Timezone Session was organised in co-operation with the African Academy of Neurology with the aim of highlighting efforts to improve accessibility to care for people with neurological diseases in Africa.

This year we had the opportunity to see the presentation of two new guidelines and get insight into the guideline development process in this Special Session on New Neurological Guidelines.

The European Basal Ganglia Club is a traditional appointment at the annual EAN conference to receive updates about therapies and management strategies of Parkinson’s Disease.

The aim of this special edition/symposium was to give the general neurologist an overview of the current knowledge of therapeutically relevant pathomechanisms and relevant translational research.

This interesting session at EAN 2022 covered the current evidence and guidance on the management of epilepsies.

Today’s joint session with the European Sleep Research Society (ESRS) on The Burden of Sleep Disorders in Neurology was one of a number of sessions dedicated to sleep specialists as part of the Sub-specialty Track on Sleep-Wake Disorders Day on Saturday, 25 June at EAN 2022.

This joint session in cooperation with the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) covered a broad spectrum of important hot topics on multiple sclerosis.

This Symposium on ‘Early detection and treatment of Parkinson’s disease’ was organised in co-operation with the International Parkinson and Movement Disorder Society – European Section.

This interesting joint session with the European Association of Neuro-Oncology (EANO) provided a picture of biomarkers in Neuro-Oncology including imaging, biological and clinical features.

The RRFS Special Session on Unveiling research in Neurology was among the first events at EAN 2022, providing residents and students with examples and suggestions of different aspects of research in neurology.

In this population-based study, the authors aimed to investigate whether increased life expectancy determined by the adherence to a healthy lifestyle has an impact on the overall years lived with AD across the lifespan.

To evaluate the association of COVID-19 infection with olfactory bulb, our authors of the month conducted this multicenter postmortem cohort study, using ultrastructural and histopathological analysis.

Our authors of the month evaluated an experimental treatment for human prion disease, based on a fully humanised monoclonal antibody (PRN100) addressed against the cellular prion protein (PrP).

Our authors of the month conducted this retrospective case-control study in order to investigate the association of AD with the risk of COVID-19 infection (adjusted for comorbidities and sociodemographic factors).

The European Academy of Neurology (EAN) is proposing a new study on the topic of sleep & wake disorders, inspired by the European Brain Council's Value of Treatment projects